Single Injection of Ganirelix in Gonadotropin Intrauterine Insemination (IUI) Cycles
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
Ovulation induction (OI) using gonadotropins is one of the most widely prescribed treatments
of infertility. One common problem encountered while attempting OI using gonadotropins is
premature ovulation. The purpose of this study is to examine the effect of a single injection
of a medication, called ganirelix, to prevent premature ovulation. Patients will be divided
into two groups. In the first group, gonadotropins will be used to stimulate the ovaries. In
the second group gonadotropins will be used in addition to a single injection of ganirelix, a
gonadotropin releasing hormone (GnRH) antagonist. Pregnancy rates will be compared between
groups.